AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
-12.54%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$1.8B
AUM Growth
+$1.8B
(-24%)
Cap. Flow
-$127M
Cap. Flow
% of AUM
-7.06%
Top 10 Holdings %
Top 10 Hldgs %
51.01%
Holding
142
New
4
Increased
8
Reduced
8
Closed
7
Top Buys
| 1 |
Scholar Rock
SRRK
|
$34.6M |
| 2 |
Fate Therapeutics
FATE
|
$14.9M |
| 3 |
Cytokinetics
CYTK
|
$10.8M |
| 4 |
Wave Life Sciences
WVE
|
$6.5M |
| 5 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$2.58M |
Top Sells
| 1 |
argenx
ARGX
|
$71M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$22.1M |
| 3 |
Protagonist Therapeutics
PTGX
|
$18.9M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$16.8M |
| 5 |
BLU
BELLUS Health Inc.
BLU
|
$13.9M |
Sector Composition
| 1 | Healthcare | 93.1% |
| 2 | Consumer Discretionary | 5.5% |
| 3 | Financials | 0.65% |
| 4 | Consumer Staples | 0.29% |
| 5 | Industrials | 0.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
argenx
ARGX
$43.6B
| $152M | 8.09% | 400,000 -187,500 | -32% | -$71M |
|
2
Lexicon Pharmaceuticals
LXRX
$400M
| $132M | 7.07% | 71,178,364 | – | – |
|
|
ONC
3
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $105M | 5.62% | 650,000 -15,000 | -2% | -$2.43M |
|
|
WW
4
DELISTED
WW International
WW
| $94.7M | 5.06% | 14,818,300 | – | – |
|
|
SGEN
5
DELISTED
Seagen Inc. Common Stock
SGEN
| $92.9M | 4.96% | 525,000 -125,000 | -19% | -$22.1M |
|
6
Alnylam Pharmaceuticals
ALNY
$58.5B
| $87.5M | 4.67% | 600,000 -50,000 | -8% | -$7.29M |
|
|
MRTX
7
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $73.8M | 3.94% | 1,100,000 -250,000 | -19% | -$16.8M |
|
|
BLU
8
DELISTED
BELLUS Health Inc.
BLU
| $64.7M | 3.45% | 7,000,000 -1,500,000 | -18% | -$13.9M |
|
|
9
Fate Therapeutics
FATE
$120M
| $64.4M | 3.44% | 2,600,000 +600,000 | +30% | +$14.9M |
|
|
10
Cytokinetics
CYTK
$4.23B
| $50.1M | 2.68% | 1,275,000 +275,000 | +28% | +$10.8M |
|
|
11
Scholar Rock
SRRK
$3.14B
| $48M | 2.57% | 8,750,034 +6,300,034 | +257% | +$34.6M |
|
12
Amicus Therapeutics
FOLD
$2.34B
| $43M | 2.29% | 4,000,000 | – | – |
|
13
Seer Inc
SEER
$115M
| $42.5M | 2.27% | 4,750,000 | – | – |
|
|
CERE
14
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $39.7M | 2.12% | 1,500,000 | – | – |
|
|
IGMS
15
DELISTED
IGM Biosciences
IGMS
| $36.1M | 1.93% | 2,000,000 | – | – |
|
|
MORF
16
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $35.8M | 1.91% | 1,650,000 | – | – |
|
17
Krystal Biotech
KRYS
$4.27B
| $32.8M | 1.75% | 500,000 | – | – |
|
18
Foghorn Therapeutics
FHTX
$286M
| $23.4M | 1.25% | 1,720,720 | – | – |
|
|
SWTX
19
DELISTED
SpringWorks Therapeutics
SWTX
| $22.2M | 1.18% | 900,000 +50,000 | +6% | +$1.23M |
|
20
Gossamer Bio
GOSS
$562M
| $19.7M | 1.05% | 2,358,968 | – | – |
|
21
Kymera Therapeutics
KYMR
$2.95B
| $19.7M | 1.05% | 1,000,000 | – | – |
|
22
Kura Oncology
KURA
$686M
| $19.2M | 1.03% | 1,050,000 | – | – |
|
|
EQRX
23
DELISTED
EQRx, Inc. Common Stock
EQRX
| $18.8M | 1% | 4,000,000 | – | – |
|
24
Schrodinger
SDGR
$1.44B
| $18.5M | 0.99% | 700,000 | – | – |
|
25
Generation Bio
GBIO
$40.4M
| $18.5M | 0.99% | 2,814,191 | – | – |
|